{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T18:41:09Z","timestamp":1769625669552,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.juro.2016.04.075","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T09:56:58Z","timestamp":1462096618000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy"],"prefix":"10.1097","volume":"196","author":[{"given":"Allison H.","family":"Feibus","sequence":"first","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnarao","family":"Moparty","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Chagin","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Cancer Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Kattan","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Cancer Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Ledet","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.04.075_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2016.04.075_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pros.20052","article-title":"Explaining racial differences in prostate cancer in the United States: sociology or biology?","volume":"62","author":"Freedland","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2016.04.075_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.eururo.2007.08.006","article-title":"Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature","volume":"52","author":"Scattoni","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.075_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.04.075_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.1995.03530160029029","article-title":"Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men","volume":"274","author":"Moul","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2016.04.075_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/89.2.134","article-title":"Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer","volume":"89","author":"Henderson","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.04.075_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/90.10.756","article-title":"Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer","volume":"90","author":"Eastham","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.04.075_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2016.04.075_bib9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.04.075_bib10","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","article-title":"The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status","volume":"21","author":"Gohagan","year":"2000","journal-title":"Contol Clin Trials, suppl."},{"key":"10.1016\/j.juro.2016.04.075_bib11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.04.075_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2016.04.075_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1198\/000313008X370302","article-title":"Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers","volume":"62","author":"Vickers","year":"2008","journal-title":"Am Stat"},{"key":"10.1016\/j.juro.2016.04.075_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","article-title":"Urine TMPRSS2:ERG plus PCA3 for individualized prostate cancer risk assessment","volume":"70","author":"Tomlins","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.04.075_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199608013350502","article-title":"Age-specific reference ranges for prostate-specific antigen in black men","volume":"335","author":"Morgan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.04.075_bib16","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0022-5347(05)67644-6","article-title":"Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng\/ml","volume":"163","author":"Fowler","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.04.075_bib17","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1464-410X.2011.10202.x","article-title":"The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting","volume":"108","author":"Adam","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.04.075_bib18","doi-asserted-by":"crossref","first-page":"94ra72","DOI":"10.1126\/scitranslmed.3001970","article-title":"Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA","volume":"3","author":"Tomlins","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.juro.2016.04.075_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.04.075_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.21265","article-title":"TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients","volume":"71","author":"Magi-Galluzzi","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2016.04.075_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.urology.2012.07.001","article-title":"Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer","volume":"80","author":"Rosen","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.04.075_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/1055-9965.EPI-12-1238","article-title":"Genes associated with prostate cancer are differentially expressed in African American and European American men","volume":"22","author":"Powell","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2016.04.075_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3892\/mco.2014.378","article-title":"Predominance of\u00a0ERG-negative high-grade prostate cancers in\u00a0African American men","volume":"2","author":"Farrell","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.juro.2016.04.075_bib24","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-13-2265","article-title":"Evidence for molecular differences in prostate cancer between African American and Caucasian men","volume":"20","author":"Khani","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2016.04.075_bib25","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1158\/1078-0432.CCR-07-0700","article-title":"Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer","volume":"13","author":"Hessels","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2016.04.075_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.urology.2014.06.064","article-title":"Active surveillance of African American men","volume":"84","author":"Silberstein","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.04.075_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2016.04.075_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.22722","article-title":"Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP)","volume":"74","author":"Bensen","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2016.04.075_bib29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/cncr.28483","article-title":"Racial\/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute\u2019s Community Cancer Centers Program","volume":"120","author":"Langford","year":"2014","journal-title":"Cancer"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471630324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471630324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.04.075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:35:55Z","timestamp":1651206955000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.04.075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1016\/j.juro.2016.04.075"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.04.075","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.04.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}